๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Preparation, solubility, and cytocompatibility of zinc-releasing calcium phosphate ceramics

โœ Scribed by Ito, Atsuo ;Ojima, Kenji ;Naito, Hiroshi ;Ichinose, Noboru ;Tateishi, Tetsuya


Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
291 KB
Volume
50
Category
Article
ISSN
0021-9304

No coin nor oath required. For personal study only.

โœฆ Synopsis


Zinc is an essential trace element with stimulatory effects on bone formation. Therefore, zinc was doped into โค-tricalcium phosphate to develop zinc-releasing biomaterials to promote bone formation. The zinc-doped โค-tricalcium phosphate, โค-tricalcium phosphate, and hydroxyapatite powders were mixed at a (Ca+Zn)/P molar ratio of 1.60, followed by sintering into a dense body at 1100ยฐC for 1 h. The sintered body was a composite ceramic consisting of zinc-doped โค-tricalcium phosphate and hydroxyapatite phases. The composite ceramic contained zinc oxide when the zinc content was higher than 1.20 wt %. The composite ceramic released zinc under pseudophysiological conditions. However, the release of calcium and phosphate de-creased with an increase in zinc content in a range higher than 0.12 wt % owing to a decrease in solubility of the zincdoped โค-tricalcium phosphate phase. Proliferation of osteoblastic MC3T3-E1 cells was significantly increased on the composite ceramic with a zinc content from 0.6 to 1.20 wt %, compared with those without zinc. When the zinc content was higher than 1.20 wt %, release of zinc from the zinc oxide caused cytotoxicity. Therefore, the zinc content of the composite ceramic must be <1.20 wt %.


๐Ÿ“œ SIMILAR VOLUMES


Long-term implantation of zinc-releasing
โœ Kawamura, H. ;Ito, A. ;Muramatsu, T. ;Miyakawa, S. ;Ochiai, N. ;Tateishi, T. ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 403 KB

## Abstract Zinc is an essential trace element that has stimulatory effects on bone formation. Recently, we developed zincโ€releasing calcium phosphate ceramics in order to add the pharmacologic effect of zinc to calcium phosphate ceramics. In our previous study, we showed that the optimum zinc cont

Osteogenic differentiation of cultured r
โœ Ikeuchi, Masako ;Ito, Atsuo ;Dohi, Yoshiko ;Ohgushi, Hajime ;Shimaoka, Hideki ;Y ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 337 KB ๐Ÿ‘ 1 views

## Abstract Rat and human bone marrow cells (BMCs) were cultured on a composite ceramic of zincโ€containing ฮฒโ€tricalcium phosphate and hydroxyapatite (ZnTCP/HAP) with a (Ca+Zn)/P molar ratio of 1.60 and varying zinc contents. After a 2โ€week culture of the BMCs in the presence of ฮฒโ€glycerophosphate a

Stimulatory effect of zinc-releasing cal
โœ Kawamura, Haruo ;Ito, Atsuo ;Miyakawa, Shunpei ;Layrolle, Pierre ;Ojima, Kenji ; ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 631 KB

Although hydroxyapatite (HAP) and tricalcium phosphate (TCP) are currently used as bone graft substitutes or coatings on metallic prostheses because of their excellent biocompatibility and osteoconductivity, they do not stimulate bone formation or inhibit bone resorption. Zinc, an essential trace el

In vitro studies of calcium phosphate gl
โœ A. G. Dias; M. A. Lopes; A. T. Trigo Cabral; J. D. Santos; M. H. Fernandes ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 467 KB ๐Ÿ‘ 2 views

## Abstract Two glass ceramics in the CaO๏ฃฟP~2~O~5~๏ฃฟMgO system with the incorporation of K~2~O or TiO~2~ oxides were prepared with the goal of using them as potential bone graft substitutes. The incorporation of TiO~2~ and K~2~O led to the preparation of specific crystalline phases in the structure

Efficacy of the injectable calcium phosp
โœ Makoto Otsuka; Ayako Oshinbe; Racquel Z. LeGeros; Yoshihiro Tokudome; Atsuo Ito; ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 461 KB

The purpose of this study was to evaluate the therapeutic efficacy of a new calcium phosphate (CaP)-based formulation in improving the bone mineral deficiency in ovariectomized (OVX) rats. The ions release experiments for CaP preparations (G2: 0.46% Mg, 5.78% Zn, and 2.5% F; G3:3.1% Mg, 0.03% Zn, an